Når opløsningen er fortyndet (se sektion 6. 6), indeholder infusionsvæsken cirka 2, 6 mg/ ml natalizumab.
When diluted (see section 6.6), the solution for infusion contains approximately 2.6 mg/ ml of natalizumab.